Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical DHEA Against Vaginal Atrophy (3-Month Placebo-Controlled Double-Blind Randomized Phase III Study)

NCT01846442 is registered in ClinicalTrials.gov with EndoCeutics Inc. as lead sponsor.

NCT NCT01846442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01846442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical DHEA Against Vaginal Atrophy (3-Month Placebo-Controlled Double-Blind Randomized Phase III Study)
Lead sponsor
EndoCeutics Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2007
Completion date
October 31, 2008
Enrollment
218 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal atrophy